PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $29,355,000 | +5.0% | 9,318,552 | -3.0% | 0.01% | 0.0% |
| Q2 2020 | $27,946,000 | +3.0% | 9,603,719 | -0.2% | 0.01% | -14.3% |
| Q1 2020 | $27,131,000 | -12.3% | 9,621,059 | +0.9% | 0.01% | +27.3% |
| Q4 2019 | $30,928,000 | +40.2% | 9,530,949 | -6.7% | 0.01% | +22.2% |
| Q3 2019 | $22,059,000 | -36.4% | 10,212,232 | -7.6% | 0.01% | -30.8% |
| Q2 2019 | $34,688,000 | -22.6% | 11,047,261 | -8.3% | 0.01% | -27.8% |
| Q1 2019 | $44,802,000 | +24.1% | 12,043,406 | -3.3% | 0.02% | +12.5% |
| Q4 2018 | $36,113,000 | +8.9% | 12,453,121 | -1.3% | 0.02% | +23.1% |
| Q3 2018 | $33,173,000 | +13.3% | 12,613,444 | +0.8% | 0.01% | +8.3% |
| Q2 2018 | $29,284,000 | -13.5% | 12,514,490 | +8.7% | 0.01% | -14.3% |
| Q1 2018 | $33,862,000 | +19.0% | 11,517,800 | +10.9% | 0.01% | +16.7% |
| Q4 2017 | $28,465,000 | -3.6% | 10,388,372 | +19.3% | 0.01% | -7.7% |
| Q3 2017 | $29,518,000 | +60.9% | 8,707,461 | +17.2% | 0.01% | +62.5% |
| Q2 2017 | $18,348,000 | +42.2% | 7,428,030 | +30.7% | 0.01% | +33.3% |
| Q1 2017 | $12,901,000 | +42.1% | 5,683,650 | +32.7% | 0.01% | +20.0% |
| Q4 2016 | $9,078,000 | -26.8% | 4,282,180 | +15.7% | 0.01% | -28.6% |
| Q3 2016 | $12,394,000 | +7.3% | 3,699,915 | +0.6% | 0.01% | 0.0% |
| Q2 2016 | $11,553,000 | +5.8% | 3,679,215 | +12.2% | 0.01% | 0.0% |
| Q1 2016 | $10,916,000 | +6.6% | 3,278,389 | +13.4% | 0.01% | +16.7% |
| Q4 2015 | $10,237,000 | -26.0% | 2,891,641 | +5.1% | 0.01% | -33.3% |
| Q3 2015 | $13,839,000 | -21.9% | 2,751,402 | -0.1% | 0.01% | -18.2% |
| Q2 2015 | $17,711,000 | -6.4% | 2,754,502 | +2.4% | 0.01% | -8.3% |
| Q1 2015 | $18,930,000 | -8.8% | 2,690,741 | -0.0% | 0.01% | -14.3% |
| Q4 2014 | $20,747,000 | +2.2% | 2,690,941 | -1.0% | 0.01% | 0.0% |
| Q3 2014 | $20,295,000 | -22.8% | 2,716,799 | +0.1% | 0.01% | -22.2% |
| Q2 2014 | $26,272,000 | +16.1% | 2,714,023 | -0.3% | 0.02% | +5.9% |
| Q1 2014 | $22,621,000 | -2.6% | 2,722,123 | -1.1% | 0.02% | -5.6% |
| Q4 2013 | $23,224,000 | +2.8% | 2,751,695 | -3.0% | 0.02% | -10.0% |
| Q3 2013 | $22,602,000 | +2.8% | 2,835,691 | -0.5% | 0.02% | -4.8% |
| Q2 2013 | $21,997,000 | – | 2,849,419 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,585,500 | $3,710,000 | 1.36% |
| SMH CAPITAL ADVISORS INC | 83,369 | $195,000 | 0.32% |
| West Family Investments, Inc. | 338,141 | $791,000 | 0.20% |
| Matarin Capital Management, LLC | 927,289 | $2,169,856,000 | 0.16% |
| ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $33,000 | 0.12% |
| Alambic Investment Management, L.P. | 163,200 | $382,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,760,376 | $4,119,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 5,677,647 | $13,286,000 | 0.08% |
| Zebra Capital Management LLC | 67,892 | $159,000 | 0.07% |
| Fortis Advisors, LLC | 45,602 | $107,000 | 0.06% |